Artigo Revisado por pares

The Relative Proportion of Stromal and Epithelial Hyperplasia is Related to the Development of Symptomatic Benign Prostate Hyperplasia

1992; Lippincott Williams & Wilkins; Volume: 147; Issue: 5 Linguagem: Inglês

10.1016/s0022-5347(17)37546-8

ISSN

1527-3792

Autores

Ellen Shapiro, Michael J. Becich, Victor Hartanto, Herbert Lepor,

Tópico(s)

Urologic and reproductive health conditions

Resumo

No AccessJournal of Urology1 May 1992The Relative Proportion of Stromal and Epithelial Hyperplasia is Related to the Development of Symptomatic Benign Prostate Hyperplasia Ellen Shapiro, Michael J. Becich, Victor Hartanto, and Herbert Lepor Ellen ShapiroEllen Shapiro , Michael J. BecichMichael J. Becich , Victor HartantoVictor Hartanto , and Herbert LeporHerbert Lepor View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)37546-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail The specific features of the prostate adenoma predisposing to the development of symptomatic benign prostatic hyperplasia (BPH) are unknown. Our objective was to determine whether the histological composition of the prostate adenoma is related to the development of symptomatic BPH. Prostate adenomas were obtained from men with asymptomatic BPH undergoing cystoprostatectomy for invasive transitional cell carcinoma, and from men with symptomatic BPH undergoing open prostatectomy, transurethral resection of the prostate and pharmacotherapy. The severity of bladder outlet obstruction was evaluated with the Boyarsky symptom score and uroflowmetry. The percentages of stroma, epithelium and glandular lumen were determined in the prostate adenomas via quantitative image analysis on a computer-assisted morphometry system. The prostate adenomas from the 33 men with symptomatic BPH contained 62 ± 1%, 15 ± 1% and 23 ± 1% of stroma, epithelium and glandular lumen, respectively. The prostate adenomas from 6 men with asymptomatic disease contained 54 ± 1%, 21 ± 1% and 25 ± 1% of stroma, epithelium and glandular lumen, respectively. The ratios of stromal-to-epithelial hyperplasia in the prostate adenomas from men with symptomatic and asymptomatic disease were 4.6 ± 0.3 and 2.7 ± 0.1, respectively. The differences in percentage of stroma and epithelium, and the stromal-to-epithelial ratio in the prostate adenomas from men with symptomatic and asymptomatic BPH were statistically significant. Our study suggests that the histological composition of the prostate adenoma is related to the development of symptomatic BPH. © 1992 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByGupta N and McVary K (2016) Physiological and Pharmacological Studies of the Prostate GlandJournal of Urology, VOL. 197, NO. 2S, (S26-S27), Online publication date: 1-Feb-2017.Hinata N, Miyake H, Murakami G, Abe S and Fujisawa M (2018) Bladder Neck Muscle Degeneration in Patients with Prostatic HyperplasiaJournal of Urology, VOL. 195, NO. 1, (206-212), Online publication date: 1-Jan-2016.Matsukawa Y, Gotoh M, Komatsu T, Funahashi Y, Sassa N and Hattori R (2018) Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow StudyJournal of Urology, VOL. 189, NO. 1S, (S117-S121), Online publication date: 1-Jan-2013.Kojima Y, Sasaki S, Kubota Y, Imura M, Oda N, Kiniwa M, Hayashi Y and Kohri K (2018) Up-Regulation of α1a and α1d-Adrenoceptors in the Prostate by Administration of Subtype Selective α1-Adrenoceptor Antagonist Tamsulosin in Patients With Benign Prostatic HyperplasiaJournal of Urology, VOL. 186, NO. 4, (1530-1536), Online publication date: 1-Oct-2011.Morishima S, Suzuki F, Nishimune A, Yoshiki H, Akino H, Yokoyama O and Muramatsu I (2018) Visualization and Tissue Distribution of α1L-Adrenoceptor in Human Prostate by the Fluorescently Labeled Ligand Alexa-488-SilodosinJournal of Urology, VOL. 183, NO. 2, (812-819), Online publication date: 1-Feb-2010.Mori F, Oda N, Sakuragi M, Sakakibara F, Kiniwa M and Miyoshi K (2018) New Histopathological Experimental Model for Benign Prostatic Hyperplasia: Stromal Hyperplasia in RatsJournal of Urology, VOL. 181, NO. 2, (890-898), Online publication date: 1-Feb-2009.Matsukawa Y, Gotoh M, Komatsu T, Funahashi Y, Sassa N and Hattori R (2018) Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow StudyJournal of Urology, VOL. 182, NO. 6, (2831-2835), Online publication date: 1-Dec-2009.Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O and Muramatsu I (2018) Identification of α-1L and α-1A Adrenoceptors in Human Prostate by Tissue Segment BindingJournal of Urology, VOL. 177, NO. 1, (377-381), Online publication date: 1-Jan-2007.SHARIAT S, ASHFAQ R, ROEHRBORN C, SLAWIN K and LOTAN Y (2018) EXPRESSION OF SURVIVIN AND APOPTOTIC BIOMARKERS IN BENIGN PROSTATIC HYPERPLASIAJournal of Urology, VOL. 174, NO. 5, (2046-2050), Online publication date: 1-Nov-2005.HONG J, SONG C, SHIN Y, KIM H, CHO S, KIM W and AHN H (2018) Estrogen Induction of Smooth Muscle Differentiation of Human Prostatic Stromal Cells is Mediated by Transforming Growth Factor-βJournal of Urology, VOL. 171, NO. 5, (1965-1969), Online publication date: 1-May-2004.KYPRIANOU N (2018) Doxazosin and Terazosin Suppress Prostate Growth by Inducing Apoptosis: Clinical SignificanceJournal of Urology, VOL. 169, NO. 4, (1520-1525), Online publication date: 1-Apr-2003.KOZLOWSKI R, KERSHEN R, SIROKY M, KRANE R and AZADZOI K (2018) CHRONIC ISCHEMIA ALTERS PROSTATE STRUCTURE AND REACTIVITY IN RABBITSJournal of Urology, VOL. 165, NO. 3, (1019-1026), Online publication date: 1-Mar-2001.SHIBATA Y, FUKABORI Y, ITO K, SUZUKI K and YAMANAKA H (2018) COMPARISON OF HISTOLOGICAL COMPOSITIONS AND APOPTOSIS IN CANINE SPONTANEOUS BENIGN PROSTATIC HYPERPLASIA TREATED WITH ANDROGEN SUPPRESSIVE AGENTS CHLORMADINONE ACETATE AND FINASTERIDEJournal of Urology, VOL. 165, NO. 1, (289-293), Online publication date: 1-Jan-2001.MARCELLI M, SHAO T, LI X, YIN H, MARANI M, DENNER L, TENG B and CUNNINGHAM G (2018) INDUCTION OF APOPTOSIS IN BPH STROMAL CELLS BY ADENOVIRAL-MEDIATED OVEREXPRESSION OF CASPASE-7Journal of Urology, VOL. 164, NO. 2, (518-525), Online publication date: 1-Aug-2000.MURATA S, TANIGUCHI T, TAKAHASHI M, OKADA K, AKIYAMA K and MURAMATSU I (2018) TISSUE SELECTIVITY OF KMD-3213, AN α1-ADRENOCEPTOR ANTAGONIST, IN HUMAN PROSTATE AND VASCULATUREJournal of Urology, VOL. 164, NO. 2, (578-583), Online publication date: 1-Aug-2000.SCHUSTER G and SCHUSTER T (2018) THE RELATIVE AMOUNT OF EPITHELIUM, MUSCLE, CONNECTIVE TISSUE AND LUMEN IN PROSTATIC HYPERPLASIA AS A FUNCTION OF THE MASS OF TISSUE RESECTEDJournal of Urology, VOL. 161, NO. 4, (1168-1173), Online publication date: 1-Apr-1999.ROPIQUET F, GIRI D, LAMB D and ITTMANN M (2018) FGF7 AND FGF2 ARE INCREASED IN BENIGN PROSTATIC HYPERPLASIA AND ARE ASSOCIATED WITH INCREASED PROLIFERATIONJournal of Urology, VOL. 162, NO. 2, (595-599), Online publication date: 1-Aug-1999.MALLOY B, PRICE D, PRICE R, BIENSTOCK A, DOLE M, FUNK B, RUDNER X, RICHARDSON C, DONATUCCI C and SCHWINN D (2018) alpha1-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN DETRUSORJournal of Urology, VOL. 160, NO. 3 Part 1, (937-943), Online publication date: 1-Sep-1998.Jonler M and Bruskewitz R (2018) Prostatic Histology in Secondary Transurethral Resection of the ProstateJournal of Urology, VOL. 154, NO. 1, (119-122), Online publication date: 1-Jul-1995.Begun F, Story M, Hopp K, Shapiro E and Lawson R (2018) Investigative Urology: Regional Concentration of Basic Fibroblast Growth Factor in Normal and Benign Hyperplastic Human ProstatesJournal of Urology, VOL. 153, NO. 3, (839-843), Online publication date: 1-Mar-1995.Costello A, Bolton D, Ellis D and Crowe H (2018) Histopathological Changes in Human Prostatic Adenoma Following Neodymium:Yag Laser Ablation TherapyJournal of Urology, VOL. 152, NO. 5 Part 1, (1526-1529), Online publication date: 1-Nov-1994.Price D, Schwinn D, Lomasney J, Allen L, Caron M and Lefkowitz R (2018) Identification, Quantification, and Localization of mRNA for Three Distinct Alpha1 Adrenergic Receptor Subtypes in Human ProstateJournal of Urology, VOL. 150, NO. 2 Part 1, (546-551), Online publication date: 1-Aug-1993. Volume 147Issue 5May 1992Page: 1293-1297 Advertisement Copyright & Permissions© 1992 by The American Urological Association Education and Research, Inc.Keywordsepitheliumprostatic diseasesprostatic hypertrophyMetricsAuthor Information Ellen Shapiro More articles by this author Michael J. Becich More articles by this author Victor Hartanto More articles by this author Herbert Lepor More articles by this author Expand All Advertisement Loading ...

Referência(s)
Altmetric
PlumX